References
- Blair J E, Williams R EO. Phage typing of staphylococci. Bull WHO 1961; 24: 771–784
- Hedström SÅ, Kahlmeter O. Dicloxacillin and flucloxacillin twice daily with probenecid in staphylococcal infections. A clinical and pharmacokinetic evaluation. Scand J Infect Dis 1980; 12: 221–225
- Hedström SÅ. Behandling av recidiverande furunkulos. Stafylokockinfektioner, SÅ Hedström. Astra Läkemedel, Södertälje 1979; 53–59
- White A C, Brooks GF. Furunculosis, pyoderma and impetigo. Infectious diseases, PD Hoeprich. Harper & Row, New York, San Francisco, London 1977; 785–793
- Strauss W G, Maibach H I, Shinefield HR. Bacterial interference of recurrent furunculosis. JAMA 1969; 208: 861–863
- Steele RW. Recurrent staphylococcal infection in families. Arch Dermatol 1980; 116: 189–190
- Hedström SÅ. Recurrent staphylococcal furunculosis. Bacteriological findings and epidemiology in 100 cases. Scand J Infect Dis 1981; 13: 115–119
- Hedström SÅ. Recurrent staphylococcal furunculosis: Dissemination of phage group II strains in familial infections. Zentralbl Bakteriol Suppl 1981; 10: 975–979
- Drutz D J, Van Way N H, Schaffner W, Koenig G. Bacterial interference in the therapy of recurrent staphylococcal infections: Multiple abscesses due to the implantation of the 502 A strain of Staphylococcus. N Engl J Med 1966; 275: 1161–1165